Health
ColCORONA: Colchicine Reduces Complications in Outpatient COVID-19 – Medscape
The primary endpoint was not significant in the overall population, but in those with PCR-confirmed COVID, treatment reduced hospitalization, need for ventilation,…
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.
The oral, anti-inflammatory drug colchicine can prevent complications and hospitalizations in nonhospitalized patients newly diagnosed with COVID-19, according to a press release from the ColCORONA trial investigators.
After 1 month of therapy, there was a 21% risk reduction in the primary composite endpoint of death or hospitalizations that missed statistical significance, compared with placebo…
-
General10 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General13 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
Noosa News23 hours agoBrisbane State High School wants playing fields, not apartment towers at Visy riverside site
-
General24 hours agoNZ government’s puberty blockers move attracts strong reactions